Table 1.
Characteristic | Failed Response group | Successful Response group | p-value | |
---|---|---|---|---|
Groups based on unconstrained lean-and-release trials | N=29 | N=55 | ||
| ||||
Sex (number (%))* | Men | 19 (65.5%) | 46 (83.6%) | 0.059 |
Women | 10 (34.5%) | 9 (16.4%) | ||
Age (years)* | 66.8 (14.7) | 64.3 (12.9) | 0.43 | |
NIHSS scorea* | 3.8 (2.6) | 2.8 (2.7) | 0.17 | |
CMSA foot score (more-affected side)b* | 4.2 (1.2) | 4.7 (1.1) | 0.073 | |
Time since stroke (days)* | 23.1 (16.2) | 21.1 (11.0) | 0.50 | |
More-affected side of the body (number (%))* | Right | 9 (31.0%) | 36 (65.5%) | 0.75 |
Left | 20 (69.0%) | 19 (34.5%) | ||
Stroke type (number (%)) | Ischemic | 23 (79.3%) | 46 (83.6%) | N/A |
Haemorrhagic | 6 (20.7%) | 6 (10.9%) | ||
Transforming to haemorrhagic | 0 (0.0%) | 2 (3.6%) | ||
N/A | 0 (0.0%) | 1 (1.8%) | ||
History of or current peripheral neuropathy (number (%)) | Present | 1 (3.4%) | 3 (5.5%) | N/A |
Absent | 28 (96.6%) | 52 (94.5%) | ||
History of or current vestibular condition (number (%)) | Present | 1 (3.4%) | 3 (5.5%) | N/A |
Absent | 28 (96.6%) | 52 (94.5%) | ||
History of or current visual field deficit (number (%)) | Present | 3 (10.3%) | 6 (10.9%) | N/A |
Absent | 26 (89.7%) | 49 (89.1%) | ||
History of or current neglect (number (%)) | Present | 6 (20.7%) | 7 (12.7%) | N/A |
Absent | 23 (79.3%) | 48 (87.3%) | ||
| ||||
Groups based on encouraged-use lean-and-release trials | N=43 | N=20 | ||
| ||||
Sex (number (%))* | Men | 34 (79.1%) | 16 (80.0%) | 0.93 |
Women | 9 (20.9%) | 4 (20.0%) | ||
Age (years)* | 66.4 (13.1) | 59.5 (13.5) | 0.057 | |
NIHSS scorec* | 3.6 (2.6) | 2.6 (2.8) | 0.21 | |
CMSA foot score (more-affected side)* | 4.2 (1.0) | 5.3 (1.1) | <0.001 | |
Time since stroke (days)* | 22.3 (14.1) | 21.6 (13.5) | 0.86 | |
More-affected side of the body (number (%))* | Right | 28 (65.1%) | 16 (80.0%) | 0.23 |
Left | 15 (34.9%) | 4 (20.0%) | ||
Stroke type (number (%)) | Ischemic | 33 (76.7%) | 19 (95.0%) | N/A |
Haemorrhagic | 8 (18.6%) | 1 (5.0%) | ||
Transforming to haemorrhagic | 1 (2.3%) | 0 (0.0%) | ||
N/A | 1 (2.3%) | 0 (0.0%) | ||
History of or current peripheral neuropathy (number (%)) | Present | 2 (4.7%) | 1 (5.0%) | N/A |
Absent | 41 (95.3%) | 19 (95.0%) | ||
History of or current vestibular condition (number (%)) | Present | 2 (4.7%) | 2 (10.0%) | N/A |
Absent | 41 (95.3%) | 18 (90.0%) | ||
History of or current visual field deficit (number (%)) | Present | 2 (4.7%) | 4 (20.0%) | N/A |
Absent | 41 (95.3%) | 16 (80.0%) | ||
History of or current neglect (number (%)) | Present | 10 (23.3%) | 1 (5.0%) | N/A |
Absent | 33 (76.7%) | 19 (95.0%) |
Data available for 68 participants (Failed Response group: N=22; Successful Response group: N=46);
Data available for 82 participants (Failed Response group: N=28; Successful Response group: N=54);
Data available for 52 participants (Failed Response group: N=36; Successful Response group: N=16).